BlackRock Fund Advisors’s WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS WX Stock Holding History

BlackRock Fund Advisors’s Portfolio WX Stock Details WX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q4	–	Sell	-218	Closed	-$8K	–	3930
2014 Q3	$8K	Sell	218 -16	-7%	-$548	﹤0.01%	3802
2014 Q2	$8K	Hold	234	–	–	﹤0.01%	3759
2014 Q1	$9K	Hold	234	–	–	﹤0.01%	3739
2013 Q4	$9K	Hold	234	–	–	﹤0.01%	3740
2013 Q3	$6K	Sell	234 -96	-29%	-$2.27K	﹤0.01%	3729
2013 Q2	$7K	Buy	+330	New	+$6.44K	﹤0.01%	3708

Other funds holding WX

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

CWAM

Columbia Wanger Asset Management Chicago, Illinois $6.69B AUM 31.14% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

CBOA

Commonwealth Bank of Australia Sydney, NSW, Australia $231M AUM

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

CGI

Comgest Global Investors Paris, France $4.59B AUM 12.96% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return

BlackRock Fund Advisors's WX Position: Q4 2014 in Review

BlackRock Fund Advisors sold out of WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS (WX) in Q4 2014, closing a stake of 218 shares — an estimated $8K sold.

BlackRock Fund Advisors first reported a position in WX in Q2 2013 and held it in 6 quarters. The position peaked at $9K in Q1 2014. 165 funds tracked by Wall St. Rank hold WX as of Q4 2014.

BlackRock Fund Advisors reported no remaining WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS position as of Q4 2014 after selling out during the quarter.
BlackRock Fund Advisors sold 218 WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS shares in Q4 2014, an estimated $8K.
BlackRock Fund Advisors first reported a position in WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS in Q2 2013 and held it in 6 quarters.
BlackRock Fund Advisors's WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS position peaked at $9K in Q1 2014.
165 funds tracked by Wall St. Rank held WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS as of Q4 2014.

Based on BlackRock Fund Advisors's 13F filing for Q4 2014, filed 9 Feb 2015.